Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...
An opportunity to reduce global burden of stroke-related disability SAN ANTONIO, Feb. 4, 2026 /PRNewswire/ -- For many stroke survivors, recovery is derailed by painful muscle stiffness and ...
Botulinum toxin therapy has emerged as a pivotal treatment in the management of spasticity, a debilitating neuromuscular condition characterised by increased muscle tone and hyperactive reflexes. By ...
Please provide your email address to receive an email when new articles are posted on . The U.S. Departments of Veterans Affairs and Defense updated their clinical practice guidance for managing ...
News-Medical.Net on MSN
Hip exoskeleton reduces walking effort in stroke survivors
A leading cause of disability in the United States is hemiparesis, a condition where impaired motor control, muscle weakness, and spasticity affect one side of the body. Occurring in 80% of stroke ...
SAN ANTONIO, Feb. 4, 2026 – For many stroke survivors, recovery is derailed by painful muscle stiffness and involuntary spasms that limit movement, independence and quality of life. Often viewed as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results